Invited to address the British Orthopaedic Association's Annual Congress in Liverpool, FIPO Vice Chairman Charlie Chan highlighted concerns about the impact of Private Medical Insurance practices on consultants and patients, giving rise to restrictions on patient choice.
He outlined FIPO's view that the current PMI fee-setting model suppresses consultant earnings while simultaneously reducing patient access to their preferred specialist.
FIPO's engagement with the BOA reflects the breadth of medical specialties affected by these practices and the growing consensus that reform is overdue.
The BOA represents over 4,000 orthopaedic surgeons and trainees across the UK, making this a significant opportunity to build awareness of the ongoing competition law action.
